A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...

A study published in Cell Reports Medicine reveals that bowel movement frequency significantly influences physiology and long ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

Explore the causes of itching in liver diseases and tips to relieve discomfort. Learn about treatments for pruritus and when ...

NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver diseases such as primary sclerosing cholangitis (PSC ...

PSC is a rare and devastating liver disease with no treatments or cure. This grant enables us to build on work that maps PSC liver cells for pursuing preclinical drug development. With an ...

The American Association for the Study of Liver Diseases (AASLD) is inviting members to apply as site principal investigators to participate in TARGET-LD, which broadly studies outcomes for patients ...

Barry had been diagnosed with primary sclerosing cholangitis (PSC), a rare liver disease for which there is no cure but which some people can live with for years without problems. Among those who ...

In contrast with PSC, in which the etiology is unknown and ... cholangitis usually have no history of prior biliary disease or liver disease and no evidence of a pathological process or injury ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...